Cervical Cancer

GSK Does Not Expect FDA Approval Of HPV Vaccine Cervarix Until End Of 2009
GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its human papillomavirus vaccine Cervarix until late 2009, Reuters reports. GSK said it has decided to wait until results from a Phase III trial of the vaccine are available before seeking U.S. approval.